Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.

ग्रंथसूची विवरण
मुख्य लेखकों:	Seeman, A, McClung, M, Zippel, H, Bensen, W, Cooper, C, Benhamou, C, DiGennaro, J, Zorich, N, Reginster, J
स्वरूप:	Journal article
प्रकाशित:	2000

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
द्वारा: Cooper, C, और अन्य
प्रकाशित: (2001)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
द्वारा: Tahir Masud, और अन्य
प्रकाशित: (2009-11-01)

Once-monthly risedronate for postmenopausal osteoporosis
द्वारा: Kristina Casadei, और अन्य
प्रकाशित: (2009-02-01)

Romosozumab for the treatment of osteoporosis
द्वारा: Michael R. McClung
प्रकाशित: (2018-03-01)

Emerging Therapies for Osteoporosis
द्वारा: Michael R. McClung
प्रकाशित: (2015-12-01)

Denosumab for the treatment of osteoporosis
द्वारा: Michael R. McClung
प्रकाशित: (2017-03-01)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
द्वारा: Raja Bobba, और अन्य
प्रकाशित: (2007-10-01)

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.
द्वारा: Sorensen, O, और अन्य
प्रकाशित: (2003)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
द्वारा: María J Moro-Álvarez, और अन्य
प्रकाशित: (2008-06-01)

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
द्वारा: Mizue Tanaka, और अन्य
प्रकाशित: (2014-01-01)

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
द्वारा: Boyanov M, और अन्य
प्रकाशित: (2012-04-01)

Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
द्वारा: Ban Hadi Hameed
प्रकाशित: (2018-10-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
द्वारा: Paula Rackoff
प्रकाशित: (2009-05-01)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
द्वारा: Stefano Palomba, और अन्य
प्रकाशित: (2010-06-01)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
द्वारा: Delmas, P, और अन्य
प्रकाशित: (2005)

The International Osteoporosis Foundation: history, objectives and achievements.
द्वारा: Cooper, C, और अन्य
प्रकाशित: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
द्वारा: Cooper, C, और अन्य
प्रकाशित: (2009)

THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
द्वारा: Adam Fajar, और अन्य
प्रकाशित: (2019-12-01)

Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement
द्वारा: Zoya Saifi, और अन्य
प्रकाशित: (2023-09-01)

Identification and treatment of osteoporosis among elderly patients with hip fractures
द्वारा: Erika Satomi, और अन्य
प्रकाशित: (2009-01-01)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
द्वारा: Watts, N, और अन्य
प्रकाशित: (2004)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
द्वारा: M Stevenson, और अन्य
प्रकाशित: (2005-06-01)

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
द्वारा: Seeman, E, और अन्य
प्रकाशित: (2010)

A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis
द्वारा: Satoshi Soen, और अन्य
प्रकाशित: (2020-12-01)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
द्वारा: Ma. Florencia Peralta, और अन्य
प्रकाशित: (2021-05-01)

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
द्वारा: Bala, Y, और अन्य
प्रकाशित: (2014)

Telecarers improve osteoporosis treatment and compliance rates in secondary osteoporosis prevention for elderly hip fracture patients
द्वारा: Linsey Utami Gani, और अन्य
प्रकाशित: (2023-04-01)

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
द्वारा: Miller, P, और अन्य
प्रकाशित: (2005)

Calcium and Strontium Coordination Polymers as Controlled Delivery Systems of the Anti-Osteoporosis Drug Risedronate and the Augmenting Effect of Solubilizers
द्वारा: Maria Vassaki, और अन्य
प्रकाशित: (2021-12-01)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
द्वारा: Calabria S, और अन्य
प्रकाशित: (2016-04-01)

Osteoclast and Sclerostin Expression in Osteocytes in the Femoral Head with Risedronate Therapy in Patients with Hip Fractures: A Retrospective Comparative Study
द्वारा: Hwan-Hee Lee, और अन्य
प्रकाशित: (2022-10-01)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
द्वारा: J Y Reginster, और अन्य
प्रकाशित: (2011-04-01)

Reduced Awareness for Osteoporosis in Hip Fracture Patients Compared to Elderly Patients Undergoing Elective Hip Replacement
द्वारा: Moritz Kraus, और अन्य
प्रकाशित: (2022-10-01)

Abdominal fat and hip fracture risk in the elderly: The Dubbo Osteoporosis Epidemiology Study
द्वारा: Center Jacqueline R, और अन्य
प्रकाशित: (2005-02-01)

Expansion of the circadian transcriptome in Brassica rapa and genome-wide diversification of paralog expression patterns
द्वारा: Kathleen Greenham, और अन्य
प्रकाशित: (2020-09-01)

Formulation and assessment of penetration potential of Risedronate chitosan nanoparticles loaded transdermal gel in the management of osteoporosis: In vitro and ex vivo screening
द्वारा: Sandhya Pathak, और अन्य
प्रकाशित: (2024-06-01)

Assessment and management of osteoporosis in elderly people
द्वारा: Dennison, E, और अन्य
प्रकाशित: (2000)

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
द्वारा: Ammarin Suwan, और अन्य
प्रकाशित: (2024-10-01)

Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
द्वारा: Ercan Madenci, और अन्य
प्रकाशित: (2003-06-01)

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
द्वारा: Vasikaran, S, और अन्य
प्रकाशित: (2011)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.

समान संसाधन

समान संसाधन